NCT00383513 - Study of Epratuzumab in Systemic Lupus Erythematosus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL

Epratuzumab

360 mg/m\^2 four consecutive 12-week maintenance cycles beginning with 2 consecutive weekly administrations each lasting ≤ 1 hour

Trial Locations (10)

Birmingham

Tucson

Los Angeles

Upland

Colorado Springs

Denver

Washington D.C.

Baltimore

Durham

Tulsa